Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Burkitt Lymphoma × Tenofovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hepatitis B, Chronic 2 Carcinoma, Hepatocellular 2 Recurrence 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Fibrosis 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 2 Vincristine 1 Thiotepa 1 Tenofovir 1 Radiotherapy 1 Methotrexate 1 Melphalan 1 Lomustine 1 Ifosfamide 1 Idarubicin 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cytarabine 1 Carmustine 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02585947 2016-12-21

To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma

Seoul National University Hospital

Phase 4 Unknown

Burkitt Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡